Advanced search
Publication Cover
Toxicology Communications Volume 8, 2024 - Issue 1
Submit an article Journal homepage
449
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Hypersensitivity reactions due to North American pit viper antivenom administration and confirmed elevation of alpha-gal IgE

William BannerOklahoma Center for Poison and Drug Information, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USACorrespondence[email protected]
View further author information
,
Kristie EdelenOklahoma Center for Poison and Drug Information, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USAView further author information
,
L. Claire EppersonOklahoma Center for Poison and Drug Information, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USAView further author information
&
Eszter MooreOklahoma Center for Poison and Drug Information, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USAView further author information
Article: 2314314 | Received 11 Nov 2023, Accepted 26 Jan 2024, Published online: 25 Mar 2024

References

  • Khobrani M, Huckleberry Y, Boesen KJ, et al. Incidence of allergic reactions to crotalidae polyvalent immune fab. Clin Toxicol. 2019;57(3):1–5. doi: 10.1080/15563650.2018.1504956.
  • Mullins ME, Gerardo CJ, Bush SP, et al. Adverse events in the efficacy of crotalidae polyvalent immune fab antivenom vs placebo in recovery from copperhead snakebite trial. South Med J. 2018;111(12):716–720. doi: 10.14423/SMJ.0000000000000902.
  • Moore E, Edelen K, Epperson C, et al. Sneaky snakebites: an overview of reported unusual clinical effects and adverse reactions to treatment with antivenom following crotalid envenomation. Clin Toxicol. 2023;61:120.
  • Chung CH, Mirakhur B, Chan E, et al. Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. N Engl J Med. 2008;358(11):1109–1117. doi: 10.1056/NEJMoa074943.
  • Platts-Mills TAE, Li RC, Keshavarz B, et al. Diagnosis and management of patients with the alpha-gal syndrome. J Allergy Clin Immunol Pract. 2020;8(1):15–23.e1. doi: 10.1016/j.jaip.2019.09.017.
  • Nwamara U, Kaplan MC, Mason N, et al. A retrospective evaluation of heparin product reactions in patients with alpha-gal allergies. Ticks Tick Borne Dis. 2022;13(1):101869. doi: 10.1016/j.ttbdis.2021.101869.
  • Cabezas-Cruz A, Hodzic A, Roman-Carrasco P, et al. Environmental and molecular drivers of the alpha-gal syndrome. Front Immunol. 2019;10:1210. doi: 10.3389/fimmu.2019.01210.
  • Chacon Osorio GR, Palraj R, van Nunen S, et al. Newly recognized alpha-gal syndrome in the upper midwestern United States. Mayo Clin Proc. 2022;97(9):1754–1755. doi: 10.1016/j.mayocp.2022.07.003.
  • Commins SP. Diagnosis & management of alpha-gal syndrome: lessons from 2,500 patients. Expert Rev Clin Immunol. 2020;16(7):667–677. doi: 10.1080/1744666X.2020.1782745.
  • Sharma SR, Karim S. Tick saliva and the alpha-gal syndrome: finding a needle in a haystack. Front Cell Infect Microbiol. 2021;11:680264. doi: 10.3389/fcimb.2021.680264.
  • Thompson JM, Carpenter A, Kersh GJ, et al. Geographic distribution of suspected alpha-gal syndrome cases – United States, January 2017–December 2022. MMWR Morb Mortal Wkly Rep. 2023;72(30):815–820. doi: 10.15585/mmwr.mm7230a2.
  • Straesser M, Keshavarz B, Borish L, et al. α-gal on crotalidae-polyvalent fab antivenom (CroFab): investigating the relevance to immediate hypersensitivity reactions. J Allergy Clin Immunol Pract. 2021;9(2):1015–1017.e1. doi: 10.1016/j.jaip.2020.10.026.
  • Griffiths A, Johnson J, Ward S, et al. Measurement of the oligosaccharide galactose-α-1,3-galactose (α-gal) in pit viper antivenom. J Med Toxicol. 2023;19(2):148.
  • Apostolovic D, Grundström J, Perusko M, et al. Course of IgE to alpha-gal in a Swedish population of alpha-gal syndrome patients. Clin Transl Allergy. 2021;11(10):e12087. doi: 10.1002/clt2.12087.
  • Nakagawa Y, Chinuki Y, Ogino R, et al. Cohort study of subclinical sensitization against galactose-alpha-1,3-galactose in Japan: prevalence and regional variations. J Dermatol. 2022;49(12):1268–1277. doi: 10.1111/1346-8138.16570.
  • Stenger F, Seidel P, Schricker T, et al. Could cat flea bites contribute to α-gal serum IgE levels in humans? J Investig Allergol Clin Immunol. 2022;32(6):494–495. doi: 10.18176/jiaci.0784.
  • Lone Star Tick surveillance. Centers for Disease Control and Prevention; 2022 [cited 2023]. Available from: https://www.cdc.gov/ticks/surveillance/LoneStarTick.html
  • James B. Pharmacoeconomic evaluation of crotalidae immune F(ab′)2 (equine) as compared to crotalidae polyvalent immune fab (ovine). Am J Health Syst Pharm. 2019;76(20):1561.
  • Apostolovic D, Krstic M, Mihailovic J, et al. Peptidomics of an in vitro digested alpha-Gal carrying protein revealed IgE-reactive peptides. Sci Rep. 2017;7(1):5201. doi: 10.1038/s41598-017-05355-4.
  • Blessmann J, Hanlodsomphou S, Santisouk B, et al. Serum IgE against galactose-alpha-1,3-galactose is common in Laotian patients with snakebite envenoming but not the major trigger for early anaphylactic reactions to antivenom. Toxicon X. 2020;7:100054. doi: 10.1016/j.toxcx.2020.100054.
  • Rizer J, Brill K, Charlton N, et al. Acute hypersensitivity reaction to crotalidae polyvalent immune fab (CroFab) as initial presentation of galactose-alpha-1,3-galactose (alpha-gal) allergy. Clin Toxicol. 2017;55(7):668–669. doi: 10.1080/15563650.2017.1313981.
  • Lepak MR, Bochenek SH, Bush SP. Severe adverse drug reaction following crotalidae polyvalent immune fab (ovine) administration for copperhead snakebite. Ann Pharmacother. 2015;49(1):145–149. doi: 10.1177/1060028014555711.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.